Technology
Health
Biotechnology

Arvinas

$25.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.21 (0.84%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Arvinas and other stocks, options, ETFs, and crypto commission-free!

About ARVN

Arvinas, Inc. Common Stock, also called Arvinas, is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Read More Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT.

Employees
83
Headquarters
New Haven, Connecticut
Founded
2013
Market Cap
780.77M
Price-Earnings Ratio
Dividend Yield
Average Volume
154.90K
High Today
$25.80
Low Today
$24.92
Open Price
$24.92
Volume
90.42K
52 Week High
$27.80
52 Week Low
$10.19

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Pharmaceutical
2018 IPO
US
North America

ARVN Earnings

-$62.38
-$41.74
-$21.10
-$0.46
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 12, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.